New Jersey-based pharmaceutical manufacturer agrees to pay over $2 million to settle allegations

U.S. Attorney Philip Sellinger announced the deal settles allegations Novel Laboratories violated the Controlled Substances Act.

News 12 Staff

Apr 11, 2024, 11:28 AM

Updated 42 days ago

Share:

A drug manufacturer based in Somerset has agreed to pay $2.25 million to the federal government.
U.S. Attorney Philip Sellinger announced Wednesday that the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
Officials say a Drug Enforcement Administration investigation revealed that Novel Laboratories failed to account for large amounts of oxycodone, hydrocodone and temazepam over a two-year period beginning in 2019.


More from News 12